
Empowering Digital Diabetes Care - Chronos Care
Chronos Care formed a strategic alliance with KDL to pioneer a pivotal application, serving thousands of diabetic users.
Patient-facing apps, clinician tools, and connected-device companions. iOS and Android software engineered to survive App Store reviews, regulatory audits, and a decade of devices.
Symptom journals, telehealth clients, medication adherence, post-op recovery. Built for the lowest-friction install and the highest retention.
Mobile-first EHR companions, bedside note capture, on-call workflows. Designed around the four-second interaction budget of clinical work.
GCP-aligned data capture, e-consent, ePROs, and remote-monitoring clients for sponsors and CROs running decentralized trials.
Bluetooth medical-device pairing, BLE ingestion, real-time sync. Companion apps for RPM, wearables, and in-home diagnostics.
Architecture review of any existing app, regulatory exposure assessment, and a written engagement plan. No commitment.
Stack choice (native vs cross-platform), data model, offline behavior, sync strategy, and the compliance posture each implies.
Two-week sprints. Working app from sprint one. CI/CD to TestFlight and Internal App Sharing from day one. You see progress every two weeks, not at the end.
Store-submission prep, accessibility audit (WCAG 2.2 AA, plus VoiceOver/TalkBack), penetration test if the data classification requires it, and the post-launch operations runbook.
Two-week sprints, demoable software every sprint, written status notes. You own the backlog and the direction. Compliance scoping happens up front so it never blocks a release. Typical first engagements run six to twelve weeks; longer relationships continue as iteration cycles. No retainers, no team-of-one risk.
Both, depending on the work. Native (Swift, Kotlin) when device APIs or performance demand it: Bluetooth medical devices, on-device ML, accessibility quirks. React Native when a single codebase across iOS and Android is the priority and the device surface is mainstream. We start with the constraint, not the framework.
Compliance scoping is part of discovery, not bolted on at the end. We've shipped apps under HIPAA (US), GDPR + MDR (EU), and FDA Class II device-companion paths. Data classification drives the architecture: at-rest encryption, key management, audit trails, consent flows, and store-submission language. We tell you the trade-offs in writing.
You do. All source, App Store and Play Store accounts, signing certificates, and analytics dashboards are yours from day one. We work in your repositories or hand over ours at the end of the engagement. Your choice.
An MVP with one platform and a small feature set typically ships in 8-14 weeks. A dual-platform app with device integration and regulatory paperwork is 16-28 weeks. We give a range in writing after discovery, and update it honestly when scope changes.
Often, yes. We start with a written architecture review: what's salvageable, what's tech-debt risk, and what needs to be rewritten before the next feature can land. Decisions stay with you. The assessment is free.
Two paths: we stay on as your mobile team and ship every sprint, or we hand over to your in-house team with documentation, CI/CD, and 4-6 weeks of pair-programming overlap. No surprise retainers either way.
We'll start with a free architecture review. Written, no commitment.